| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/24/1997 | EP0796342A2 Genetic basis of factor xiii activity |
| 09/24/1997 | EP0796321A1 E2 binding proteins |
| 09/24/1997 | EP0796112A1 Phosphocholine drug derivatives |
| 09/24/1997 | EP0796107A1 Sunscreen-wound healing composition |
| 09/24/1997 | EP0796100A1 Combined use of diclofenac and tribenoside to treat osteoarthritis |
| 09/24/1997 | EP0560928B1 Use of no for the treatment or prevention of bronchoconstriction |
| 09/24/1997 | CN1159950A Bioadhesive pharmaceutical composition for controlled release of active principles |
| 09/24/1997 | CN1159915A Neuroprotective agents |
| 09/23/1997 | US5670543 Skin disorders and aging resistance |
| 09/23/1997 | US5670542 Topical application |
| 09/23/1997 | US5670541 Skin treatment with hydroxy acids |
| 09/23/1997 | US5670537 Method for effecting tumor regression with a low dose, short infusion taxol regimen |
| 09/23/1997 | US5670504 2,6-diaryl pyridazinones with immunosuppressant activity |
| 09/23/1997 | US5670502 Method of tumor treatment |
| 09/23/1997 | US5670485 Anticoccidial methods and feedstuffs |
| 09/23/1997 | US5670480 Method of making polymers having specific properties |
| 09/20/1997 | CA2200394A1 A pharmaceutical preparation for treating blood coagulation disorders |
| 09/18/1997 | WO1997034146A1 Inhibiting protein interactions |
| 09/18/1997 | WO1997034137A2 Methods of the identification of pharmaceutically active compounds |
| 09/18/1997 | WO1997034011A1 Producer of an anti-tumour melanin-containing preparation 'astromelanin' |
| 09/18/1997 | WO1997034010A1 Producer of an anti-tumour melanin-containing preparation 'astromelanin' |
| 09/18/1997 | WO1997034002A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 09/18/1997 | WO1997033999A1 Immunity to trypanosomatids species |
| 09/18/1997 | WO1997033998A1 Targeted delivery of genes encoding interferon |
| 09/18/1997 | WO1997033902A1 Human tumor necrosis factor delta and epsilon |
| 09/18/1997 | WO1997033619A1 Improved vision through photodynamic therapy of the eye |
| 09/18/1997 | WO1997033616A1 Methods for treatment of allergic diseases with ige |
| 09/18/1997 | WO1997033609A1 VASOACTIVE EFFECTS AND FREE RADICAL GENERATION BY β-AMYLOID PEPTIDES |
| 09/18/1997 | WO1997033608A2 Antagonism of endothelin actions |
| 09/18/1997 | WO1997033606A1 PROGRAMMED CELL DEATH AND INTERLEUKIN-1$g(b) |
| 09/18/1997 | WO1997033604A1 Treatment of hiv-infection by interfering with host cell cyclophilin receptor activity |
| 09/18/1997 | WO1997033589A1 Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy |
| 09/18/1997 | WO1997033581A1 Smoking cessation treatments using naltrexone and related compounds |
| 09/18/1997 | WO1997033580A1 Maintaining kidney function during surgery or trauma |
| 09/18/1997 | WO1997033572A1 Method for preventing and treating peripheral neurophathy by administering selegiline |
| 09/18/1997 | WO1997033566A2 Composition and dosage form comprising opioid antagonist |
| 09/18/1997 | WO1997026866A3 Preparations of non-steroidal analgesics |
| 09/18/1997 | WO1997022695A3 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 09/18/1997 | WO1997022354A3 Use of a medicament and use of mixture of substances to produce a medicament |
| 09/18/1997 | DE19610635A1 Sequentielle Estrogen/Progesteronantagonist-Kombination für die Hormonersatz-Therapie Sequential estrogen / progesterone antagonist combination for hormone replacement therapy |
| 09/18/1997 | CA2248998A1 Inhibiting protein interactions |
| 09/18/1997 | CA2248684A1 Immunity to trypanosomatids species |
| 09/18/1997 | CA2248613A1 Vasoactive effects and free radical generation by .beta.-amyloid peptides |
| 09/18/1997 | CA2248551A1 Programmed cell death and interleukin-1.beta. |
| 09/18/1997 | CA2248538A1 Targeted delivery of genes encoding interferon |
| 09/18/1997 | CA2248192A1 Treatment of hiv-infection by interfering with host cell cyclophilin receptor activity |
| 09/18/1997 | CA2247804A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 09/18/1997 | CA2246427A1 Methods for treatment of allergic diseases with ige |
| 09/18/1997 | CA2220768A1 Smoking cessation treatments using naltrexone and related compounds |
| 09/17/1997 | EP0795011A1 Method and compositions for reducing cholesterol absorption |
| 09/17/1997 | EP0794794A1 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 09/17/1997 | EP0794793A1 Composition for prevention and treatment of hiv-1 infection comprising at least two different hiv-1 reverse transcriptase inhibitors |
| 09/17/1997 | EP0794787A1 Compositions for the treatment of parasitic and fungal infections |
| 09/17/1997 | EP0794772A1 A method for enhancing outflow of aqueous humor in treatment of glaucoma |
| 09/17/1997 | EP0755675B1 Dermatological and/or pharmaceutical composition, process of preparation and utilization |
| 09/17/1997 | EP0648114B1 Liposomes, method of preparing them and their use in the preparation of drugs |
| 09/17/1997 | CN1159760A Enteral vaccine for vaginal infections |
| 09/17/1997 | CN1159325A Co-therapy for Parkinson's syndrome |
| 09/16/1997 | US5668181 Use of the R-enantiomers of N-propargyl-1-aminoindan compounds for the treatment of depression |
| 09/16/1997 | US5668177 Method of treating wrinkles using tartaric acid |
| 09/16/1997 | US5668155 Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders |
| 09/16/1997 | US5668132 HIV Protease inhibitors useful for the treatment of AIDS |
| 09/16/1997 | US5668130 Medicament for treating gastrointestinal disorders |
| 09/16/1997 | US5668125 Spironolactone |
| 09/16/1997 | US5668124 Use of aldosterone antagonists to inhibit myocardial fibrosis |
| 09/16/1997 | US5668117 Nervous system disorders using aromatic acid compounds |
| 09/16/1997 | US5667800 Lotions with lipids and emulsifiers |
| 09/16/1997 | US5667775 Phosphate-binding polymers for oral administration |
| 09/16/1997 | US5667764 Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles |
| 09/12/1997 | WO1997032994A1 Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylase deficient cells |
| 09/12/1997 | WO1997032973A1 Combinations of fungal cell wall degrading enzyme and fungal cell membrane affecting compound |
| 09/12/1997 | WO1997032889A1 MURINE α(1,3)FUCOSYLTRANSFERASE Fuc-TVII, DNA ENCODING THE SAME, METHOD FOR PREPARING THE SAME, ANTIBODIES RECOGNIZING THE SAME, IMMUNOASSAYS FOR DETECTING THE SAME, PLASMIDS CONTAINING SUCH DNA, AND CELLS CONTAINING SUCH A PLASMID |
| 09/12/1997 | WO1997032607A2 Activated linkers and methods for making and purifying the same |
| 09/12/1997 | WO1997032604A1 Antiproliferative combinations, containing raf-targeted oligonucleotides and chemotherapeutic compounds |
| 09/12/1997 | WO1997032602A1 DELIVERY SYSTEM USING mAb 3E10 AND MUTANTS AND/OR FUNCTIONAL FRAGMENTS THEREOF |
| 09/12/1997 | WO1997032589A1 Combinations for treatment of proliferative diseases |
| 09/12/1997 | WO1997032588A2 Combination of dehydroepiandrosterone and aromatase inhibitors and use of this combination to produce a medicament for treating relative and absolute androgen deficiency in men |
| 09/12/1997 | WO1997032585A1 Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor |
| 09/12/1997 | WO1997032583A1 Use of csaidtm compounds as inhibitors of angiogenesis |
| 09/12/1997 | WO1997032575A1 Mercapto derivatives as inhibitors of cyclooxygenases |
| 09/12/1997 | WO1997032541A1 Angiogenic lipid formulations |
| 09/12/1997 | WO1997026880A3 Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients |
| 09/12/1997 | WO1997023598A3 A long qt syndrome gene which encodes kvlqt1 and its association with mink |
| 09/12/1997 | WO1997022698A3 Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
| 09/12/1997 | CA2248251A1 Combination of dehydroepiandrosterone and aromatase inhibitors and use of this combination for the production of a pharmaceutical agent for treating a relative and absolute andrgen deficiency in men |
| 09/12/1997 | CA2248233A1 Delivery system using mab 3e10 and mutants and/or functional fragments thereof |
| 09/12/1997 | CA2244733A1 Method for inhibiting adenylosuccinate synthetase activity in methylthioadenosine phosphorylase deficient cells |
| 09/12/1997 | CA2238029A1 Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor |
| 09/12/1997 | CA2220222A1 Angiogenic lipid formulations |
| 09/11/1997 | DE19610645A1 Kombination von Dehydroepiandrosteron und Aromatasehemmern und Verwendung dieser Kombination zur Herstellung eines Arzeimittels zur Behandlung eines relativen und absoluten Androgenmangels beim Mann Combination of dehydroepiandrosterone and aromatase inhibitors and the use of this combination being Arzeimittels for treating a relative and absolute androgen deficiency in men |
| 09/10/1997 | EP0793658A1 Oxazole derivatives as antagonists of alpha-1c adrenergic receptors |
| 09/10/1997 | EP0793500A1 Pharmaceutical compositions comprising nitric oxide-releasing biopolymers |
| 09/10/1997 | EP0793489A1 Compositions for the treatment of skin disorders |
| 09/10/1997 | EP0793486A1 cGMP-PDE INHIBITORS FOR THE TREATMENT OF ERECTILE DYSFUNCTION |
| 09/10/1997 | CN1159196A Inhibitors of interleukin-1'beta' converting enzyme |
| 09/10/1997 | CN1159158A Antibacterial oil-in-water emulsions |
| 09/09/1997 | US5665873 Inhibits reactivation of herpes virus |
| 09/09/1997 | US5665776 Mixing a pharmaceutically active first ingredient with a second ingredient |
| 09/09/1997 | US5665773 Cloprostenol and fluprostenol analogues and their use to treat glaucoma and ocular hypertension |
| 09/09/1997 | US5665761 Infusion of less than 6 hours |